Developing a minimally invasive, one-time outpatient therapy for obesity treatment.
About
Sedivention is a Germany-based medtech startup focused on developing a minimally invasive, one-time outpatient therapy for the treatment of obesity. Their approach utilizes a targeted cryo procedure delivered via a specially designed balloon catheter to interrupt hunger-related signals in the vagus nerve. This aims to address the underlying physiological mechanisms of obesity and enable sustained appetite reduction without surgery, implants, or ongoing medication. The company has developed a functional prototype and plans to advance product development, conduct a first-in-human study, and prepare for regulatory and market entry.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Sedivention do?
Sedivention is a Germany-based medtech startup focused on developing a minimally invasive, one-time outpatient therapy for the treatment of obesity. Their approach utilizes a targeted cryo procedure delivered via a specially designed balloon catheter to interrupt hunger-related signals in the vagus nerve. This aims to address the underlying physiological mechanisms of obesity and enable sustained appetite reduction without surgery, implants, or ongoing medication. The company has developed a fun…
How much funding has Sedivention raised?
Sedivention has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Sedivention headquartered?
Sedivention is headquartered in Germany.
When was Sedivention founded?
Sedivention was founded in 2021.
What industry does Sedivention operate in?
Sedivention operates in Medical Devices, Biotechnology, HealthTech, Obesity Treatment, MedTech, Biotech.